Overview
CJC‑1295 with DAC is a long‑acting synthetic analog of growth hormone–releasing hormone (GHRH). It is widely utilized in in vitro and laboratory‑based research involving pituitary‑signaling pathways, peptide–receptor interactions, and models of extended GHRH‑mediated biochemical activity. The incorporation of a Drug Affinity Complex (DAC) allows CJC‑1295 to bind to circulating albumin, making it of particular interest for studies examining prolonged receptor engagement and sustained signaling dynamics.
Molecular Characteristics
Peptide Type: Long‑acting GHRH analog with DAC
Form: Lyophilized powder
Purity: ≥ 98% (HPLC)
Storage: –20°C recommended
Research Applications
CJC‑1295 with DAC is commonly investigated in controlled laboratory environments for:
GHRH‑receptor binding and activation studies
Assay development involving extended pituitary‑signaling pathways
In vitro modeling of sustained peptide–receptor engagement
Exploration of nutrient‑responsive biochemical cascades
Biochemical analysis of long‑duration signaling mechanisms
(Fields of inquiry. Not biological outcomes.)
Mechanistic Notes (Research Context Only)
In laboratory settings, CJC‑1295 with DAC is studied for its interaction with:
Albumin‑binding mechanisms mediated by the Drug Affinity Complex
Prolonged GHRH‑receptor activation models
Pituitary‑regulated biochemical cascades
Cellular‑response pathways associated with extended peptide signaling
These statements describe mechanistic interest, not biological effects in humans or animals.
Storage & Handling
Store lyophilized peptide at –20°C
Avoid repeated freeze–thaw cycles
Handle reconstituted solutions according to institutional laboratory protocols
Important Research Notice
For laboratory research use only
Not for human consumption
Not a drug, food, or cosmetic
Not for veterinary or household use
No medical, metabolic, or body‑composition claims are made